Cancer Antigen Market, Global Outlook and Forecast 2022-2028

March 2022 | 61 pages | ID: CDC445B3F8DFEN
Market Monitor Global

Abstracts

Cancer antigens are certain types of proteins secreted into the bloodstream and can be measured in both cancers and non-cancerous conditions. Cancer antigens are the tumour markers produced by cancer cells and other cells of the body which provides information about cancer.

This report contains market size and forecasts of Cancer Antigen in Global, including the following market information:

Global Cancer Antigen Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cancer Antigen market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cancer Antigen 125 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cancer Antigen include Thermo Fisher Scientific, Roche, Tellgen, Labor Diagnostika Nord, Henso Medical (Hangzhou), Multisciences (Lianke) Biotech, Hangzhou AllTest Biotech, SHINJIN Medics and Xiamen Baysen Medica Tech. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Antigen companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cancer Antigen Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cancer Antigen Market Segment Percentages, by Type, 2021 (%)

• Cancer Antigen 125
• Cancer Antigen 15-3
• Cancer Antigen 27-29
• Cancer Antigen 19-9
• Others

Global Cancer Antigen Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cancer Antigen Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Diagnostic Centres
• Ambulatory Surgical Centres
• Others

Global Cancer Antigen Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cancer Antigen Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cancer Antigen revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cancer Antigen revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• Roche
• Tellgen
• Labor Diagnostika Nord
• Henso Medical (Hangzhou)
• Multisciences (Lianke) Biotech
• Hangzhou AllTest Biotech
• SHINJIN Medics
• Xiamen Baysen Medica Tech

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cancer Antigen Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cancer Antigen Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CANCER ANTIGEN OVERALL MARKET SIZE

2.1 Global Cancer Antigen Market Size: 2021 VS 2028
2.2 Global Cancer Antigen Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cancer Antigen Players in Global Market
3.2 Top Global Cancer Antigen Companies Ranked by Revenue
3.3 Global Cancer Antigen Revenue by Companies
3.4 Top 3 and Top 5 Cancer Antigen Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer Antigen Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Antigen Players in Global Market
  3.6.1 List of Global Tier 1 Cancer Antigen Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cancer Antigen Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cancer Antigen Market Size Markets, 2021 & 2028
  4.1.2 Cancer Antigen
  4.1.3 Cancer Antigen 15-3
  4.1.4 Cancer Antigen 27-29
  4.1.5 Cancer Antigen 19-9
  4.1.6 Others
4.2 By Type - Global Cancer Antigen Revenue & Forecasts
  4.2.1 By Type - Global Cancer Antigen Revenue, 2017-2022
  4.2.2 By Type - Global Cancer Antigen Revenue, 2023-2028
  4.2.3 By Type - Global Cancer Antigen Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cancer Antigen Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Diagnostic Centres
  5.1.4 Ambulatory Surgical Centres
  5.1.5 Others
5.2 By Application - Global Cancer Antigen Revenue & Forecasts
  5.2.1 By Application - Global Cancer Antigen Revenue, 2017-2022
  5.2.2 By Application - Global Cancer Antigen Revenue, 2023-2028
  5.2.3 By Application - Global Cancer Antigen Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cancer Antigen Market Size, 2021 & 2028
6.2 By Region - Global Cancer Antigen Revenue & Forecasts
  6.2.1 By Region - Global Cancer Antigen Revenue, 2017-2022
  6.2.2 By Region - Global Cancer Antigen Revenue, 2023-2028
  6.2.3 By Region - Global Cancer Antigen Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cancer Antigen Revenue, 2017-2028
  6.3.2 US Cancer Antigen Market Size, 2017-2028
  6.3.3 Canada Cancer Antigen Market Size, 2017-2028
  6.3.4 Mexico Cancer Antigen Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cancer Antigen Revenue, 2017-2028
  6.4.2 Germany Cancer Antigen Market Size, 2017-2028
  6.4.3 France Cancer Antigen Market Size, 2017-2028
  6.4.4 U.K. Cancer Antigen Market Size, 2017-2028
  6.4.5 Italy Cancer Antigen Market Size, 2017-2028
  6.4.6 Russia Cancer Antigen Market Size, 2017-2028
  6.4.7 Nordic Countries Cancer Antigen Market Size, 2017-2028
  6.4.8 Benelux Cancer Antigen Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cancer Antigen Revenue, 2017-2028
  6.5.2 China Cancer Antigen Market Size, 2017-2028
  6.5.3 Japan Cancer Antigen Market Size, 2017-2028
  6.5.4 South Korea Cancer Antigen Market Size, 2017-2028
  6.5.5 Southeast Asia Cancer Antigen Market Size, 2017-2028
  6.5.6 India Cancer Antigen Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cancer Antigen Revenue, 2017-2028
  6.6.2 Brazil Cancer Antigen Market Size, 2017-2028
  6.6.3 Argentina Cancer Antigen Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cancer Antigen Revenue, 2017-2028
  6.7.2 Turkey Cancer Antigen Market Size, 2017-2028
  6.7.3 Israel Cancer Antigen Market Size, 2017-2028
  6.7.4 Saudi Arabia Cancer Antigen Market Size, 2017-2028
  6.7.5 UAE Cancer Antigen Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific Cancer Antigen Major Product Offerings
  7.1.4 Thermo Fisher Scientific Cancer Antigen Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 Roche
  7.2.1 Roche Corporate Summary
  7.2.2 Roche Business Overview
  7.2.3 Roche Cancer Antigen Major Product Offerings
  7.2.4 Roche Cancer Antigen Revenue in Global Market (2017-2022)
  7.2.5 Roche Key News
7.3 Tellgen
  7.3.1 Tellgen Corporate Summary
  7.3.2 Tellgen Business Overview
  7.3.3 Tellgen Cancer Antigen Major Product Offerings
  7.3.4 Tellgen Cancer Antigen Revenue in Global Market (2017-2022)
  7.3.5 Tellgen Key News
7.4 Labor Diagnostika Nord
  7.4.1 Labor Diagnostika Nord Corporate Summary
  7.4.2 Labor Diagnostika Nord Business Overview
  7.4.3 Labor Diagnostika Nord Cancer Antigen Major Product Offerings
  7.4.4 Labor Diagnostika Nord Cancer Antigen Revenue in Global Market (2017-2022)
  7.4.5 Labor Diagnostika Nord Key News
7.5 Henso Medical (Hangzhou)
  7.5.1 Henso Medical (Hangzhou) Corporate Summary
  7.5.2 Henso Medical (Hangzhou) Business Overview
  7.5.3 Henso Medical (Hangzhou) Cancer Antigen Major Product Offerings
  7.5.4 Henso Medical (Hangzhou) Cancer Antigen Revenue in Global Market (2017-2022)
  7.5.5 Henso Medical (Hangzhou) Key News
7.6 Multisciences (Lianke) Biotech
  7.6.1 Multisciences (Lianke) Biotech Corporate Summary
  7.6.2 Multisciences (Lianke) Biotech Business Overview
  7.6.3 Multisciences (Lianke) Biotech Cancer Antigen Major Product Offerings
  7.6.4 Multisciences (Lianke) Biotech Cancer Antigen Revenue in Global Market (2017-2022)
  7.6.5 Multisciences (Lianke) Biotech Key News
7.7 Hangzhou AllTest Biotech
  7.7.1 Hangzhou AllTest Biotech Corporate Summary
  7.7.2 Hangzhou AllTest Biotech Business Overview
  7.7.3 Hangzhou AllTest Biotech Cancer Antigen Major Product Offerings
  7.7.4 Hangzhou AllTest Biotech Cancer Antigen Revenue in Global Market (2017-2022)
  7.7.5 Hangzhou AllTest Biotech Key News
7.8 SHINJIN Medics
  7.8.1 SHINJIN Medics Corporate Summary
  7.8.2 SHINJIN Medics Business Overview
  7.8.3 SHINJIN Medics Cancer Antigen Major Product Offerings
  7.8.4 SHINJIN Medics Cancer Antigen Revenue in Global Market (2017-2022)
  7.8.5 SHINJIN Medics Key News
7.9 Xiamen Baysen Medica Tech
  7.9.1 Xiamen Baysen Medica Tech Corporate Summary
  7.9.2 Xiamen Baysen Medica Tech Business Overview
  7.9.3 Xiamen Baysen Medica Tech Cancer Antigen Major Product Offerings
  7.9.4 Xiamen Baysen Medica Tech Cancer Antigen Revenue in Global Market (2017-2022)
  7.9.5 Xiamen Baysen Medica Tech Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cancer Antigen Market Opportunities & Trends in Global Market
Table 2. Cancer Antigen Market Drivers in Global Market
Table 3. Cancer Antigen Market Restraints in Global Market
Table 4. Key Players of Cancer Antigen in Global Market
Table 5. Top Cancer Antigen Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer Antigen Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer Antigen Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer Antigen Product Type
Table 9. List of Global Tier 1 Cancer Antigen Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Antigen Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cancer Antigen Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer Antigen Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer Antigen Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cancer Antigen Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer Antigen Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer Antigen Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cancer Antigen Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer Antigen Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer Antigen Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer Antigen Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer Antigen Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer Antigen Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer Antigen Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer Antigen Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer Antigen Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer Antigen Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer Antigen Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer Antigen Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer Antigen Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific Cancer Antigen Product Offerings
Table 32. Thermo Fisher Scientific Cancer Antigen Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche Cancer Antigen Product Offerings
Table 35. Roche Cancer Antigen Revenue (US$, Mn), (2017-2022)
Table 36. Tellgen Corporate Summary
Table 37. Tellgen Cancer Antigen Product Offerings
Table 38. Tellgen Cancer Antigen Revenue (US$, Mn), (2017-2022)
Table 39. Labor Diagnostika Nord Corporate Summary
Table 40. Labor Diagnostika Nord Cancer Antigen Product Offerings
Table 41. Labor Diagnostika Nord Cancer Antigen Revenue (US$, Mn), (2017-2022)
Table 42. Henso Medical (Hangzhou) Corporate Summary
Table 43. Henso Medical (Hangzhou) Cancer Antigen Product Offerings
Table 44. Henso Medical (Hangzhou) Cancer Antigen Revenue (US$, Mn), (2017-2022)
Table 45. Multisciences (Lianke) Biotech Corporate Summary
Table 46. Multisciences (Lianke) Biotech Cancer Antigen Product Offerings
Table 47. Multisciences (Lianke) Biotech Cancer Antigen Revenue (US$, Mn), (2017-2022)
Table 48. Hangzhou AllTest Biotech Corporate Summary
Table 49. Hangzhou AllTest Biotech Cancer Antigen Product Offerings
Table 50. Hangzhou AllTest Biotech Cancer Antigen Revenue (US$, Mn), (2017-2022)
Table 51. SHINJIN Medics Corporate Summary
Table 52. SHINJIN Medics Cancer Antigen Product Offerings
Table 53. SHINJIN Medics Cancer Antigen Revenue (US$, Mn), (2017-2022)
Table 54. Xiamen Baysen Medica Tech Corporate Summary
Table 55. Xiamen Baysen Medica Tech Cancer Antigen Product Offerings
Table 56. Xiamen Baysen Medica Tech Cancer Antigen Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cancer Antigen Segment by Type in 2021
Figure 2. Cancer Antigen Segment by Application in 2021
Figure 3. Global Cancer Antigen Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cancer Antigen Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Antigen Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Antigen Revenue in 2021
Figure 8. By Type - Global Cancer Antigen Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer Antigen Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer Antigen Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer Antigen Revenue Market Share, 2017-2028
Figure 12. US Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer Antigen Revenue Market Share, 2017-2028
Figure 16. Germany Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer Antigen Revenue Market Share, 2017-2028
Figure 24. China Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer Antigen Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer Antigen Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer Antigen Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Tellgen Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Labor Diagnostika Nord Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Henso Medical (Hangzhou) Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Multisciences (Lianke) Biotech Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Hangzhou AllTest Biotech Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. SHINJIN Medics Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Xiamen Baysen Medica Tech Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2017-2022)